Ioannis Kanakis

The impact of zoledronic acid therapy in survival of lung cancer patients with bone metastasis

K. Zarogoulidis, Eufimia Boutsikou, Ellada Eleftheriadou et al. · International Journal of Cancer · 2009 · 119 citations

Cancer Management, Pharmacotherapy, Zoledronic Acid Therapy +19

Serglycin Constitutively Secreted by Myeloma Plasma Cells Is a Potent Inhibitor of Bone Mineralization in Vitro

Achilleas D. Theocharis, Carina Seidel, Magne Børset et al. · Journal of Biological Chemistry · 2006 · 98 citations · Full text

Immunology, Pathology, Osteoporosis +17

Expression of matrix macromolecules and functional properties of breast cancer cells are modulated by the bisphosphonate zoledronic acid

P.G. Dedes, Chrysostomi Gialeli, Anastasios Tsonis et al. · Biochimica et Biophysica Acta (BBA) - General Subjects · 2012 · 79 citations

Matrix Macromolecules, Breast Oncology, Biochemistry +12

Determination and biological relevance of serum cross-linked type I collagen N-telopeptide and bone-specific alkaline phosphatase in breast metastatic cancer

Ioannis Kanakis, Maria Nikolaou, Dimitrios Pectasides et al. · Journal of Pharmaceutical and Biomedical Analysis · 2003 · 53 citations

Breast Oncology, Endocrine-related Cancer, Bone-specific Alkaline Phosphatase +8

Imatinib inhibits colorectal cancer cell growth and suppresses stromal‐induced growth stimulation, MT1‐MMP expression and pro‐MMP2 activation

Xanthi N. Stahtea, Andeas E. Roussidis, Ioannis Kanakis et al. · International Journal of Cancer · 2007 · 51 citations · Full text

Tumor Progress, Oncology, Pro‐mmp2 Activation +15